SciELO - Scientific Electronic Library Online

 
vol.78 número9Buscando la emetropía en cirugía de catarata con la fórmula más indicada para cada ojo según su longitud axial índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

Compartir


Archivos de la Sociedad Española de Oftalmología

versión impresa ISSN 0365-6691

Resumen

TORRON FERNANDEZ-BLANCO, C et al. Photodynamic therapy for choroidal  neovascularization not caused by age related  macular degeneration or pathologic myopia. Arch Soc Esp Oftalmol [online]. 2003, vol.78, n.9, pp.471-476. ISSN 0365-6691.

Purpose: To assess the effects of photodynamic therapy (PDT) with verteporfin on visual acuity (VA) and fluorescein angiography, in patients with subfoveal choroidal neovascularization (CNV) not secondary to age related macular degeneration (AMD) or pathologic myopia. Methods: 113 eyes from 104 patients underwent PDT due to subfoveal CNV from July 2001 to June 2002. In this study only those patients with CNV not related to AMD or pathologic myopia were included. Fluorescein angiography and visual acuity were evaluated. Results: 9 eyes from 8 patients (8.03%) showed distinct causes of CNV: 3 were idiopathic cases, 1 suffered angioid streaks, 1 was secondary to laser photocoagulation due to diabetic retinopathy, 2 had polypoidal choroidal vasculopathy and 2 central serous choroiditis. Regarding VA results, 77.7% improved or mantained the previous VA. Angiography resolution was observed in 55.5% of the cases (80% with just one PDT session). Average follow up was 10.5 months. Systemic or local complications were not observed. Conclusion: PDT may be useful in the treatment of different types of CNV due to causes other than AMD or high myopia.

Palabras clave : Photodynamic therapy; verteporfin; choroidal neovascularization.

        · resumen en Español     · texto en Español

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons